The Cancer Letter

Inside information on cancer research and drug development

Vol.
36
No.
44
December 03, 2010Dec 03, 2010
DOWNLOAD THE PDF

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

CTI Files Appeal Over FDA’s Decision on Pixantrone

NIH Defends NCI Sponsored Travel

Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects

Login

Looking for IP Login?